Amrize vs Loma Negra Compania Industrial Argentina Sociedad Anonima
AMRZ and LOMA side by side, both in materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AMRZ and LOMA compare
Amrize grew revenue faster over the last twelve months (3.5% versus −7.8% for Loma Negra Compania Industrial Argentina Sociedad Anonima).
Amrize keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with 2.8% at Loma Negra Compania Industrial Argentina Sociedad Anonima.
Amrize pays a dividend yielding 1.7%; Loma Negra Compania Industrial Argentina Sociedad Anonima does not pay one.
Amrize scores higher on the StockData Score (10 against 3 for Loma Negra Compania Industrial Argentina Sociedad Anonima), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AMRZ | LOMA |
|---|---|---|
| Size and price | ||
| Market cap | $21.2B | – |
| Share price | $39.82 | $8.22 |
| Change, 1 year | −18.4% | −30.5% |
| Change, 5 years | – | 37.2% |
| Beta (5Y) | 0.54 | 1.14 |
| Employees | 19K | – |
| StockData Score | ||
| Total score | 10 (better) | 3 |
| Valuation score | 3 (better) | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 2 (better) | 0 |
| Health score | 3 | 3 |
| Dividend score | 1 (better) | 0 |
| Valuation | ||
| P/E | 17.5× | – |
| P/S | 1.7× | – |
| P/B | 1.7× | – |
| EV/EBITDA | 9.7× | – |
| P/FCF | 19.7× | – |
| FCF yield | 5.1% | – |
| Fair value | $46.40 | – |
| Margin of safety | 14.2% | – |
| Growth | ||
| Revenue growth (TTM) | 3.5% (better) | −7.8% |
| Revenue growth, 5Y average | – | 47.3% |
| Net income growth (TTM) | 8.3% (better) | −88.3% |
| EPS growth (TTM) | 8.6% | – |
| Profitability | ||
| Gross margin | 24.8% (better) | 21.8% |
| Operating margin | 15.5% | – |
| Net margin | 10.2% (better) | 2.8% |
| FCF margin | 8.8% (better) | 0.30% |
| Return on equity | 9.8% (better) | 2.2% |
| Return on invested capital | 9.7% | – |
| Financial health | ||
| Debt / equity | 0.46 | 0.28 (better) |
| Net debt / EBITDA | 2.00 | 1.47 (better) |
| Interest coverage | 5.3× | – |
| Current ratio | 1.07 | 1.44 (better) |
| Altman Z-score | 1.96 | – |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 1.7% | – |
| Shareholder yield | 1.7% | – |
| Ownership | ||
| Held by institutions | 48.3% | 3.5% |
| Held by insiders | 7.6% | 0.00% |
| Insider net buying, 12 months | $9.9M | – |
| Superinvestors holding | 3 | – |
| Short interest, % of float | 3.0% | – |
Go deeper
- AMRZ stock overview
- AMRZ income statement
- AMRZ valuation and score
- LOMA stock overview
- LOMA income statement
- LOMA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.